Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02439736 · ClinicalTrials.gov registry record

Evaluation OF Biomarkers OF Traumatic Brain Injury Extension Study

A clinical trial of Traumatic Brain Injury, sponsored by Banyan Biomarkers.

Completed
Registry status
119
Enrollment target
7
Study locations

NCT02439736 is a study of Traumatic Brain Injury that has completed, run by Banyan Biomarkers. The registered enrollment target is 119 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (57% lower). The trial reports 7 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02439736, a study of Traumatic Brain Injury, has completed, sponsored by Banyan Biomarkers.

COMPLETED
Registry status
119 participants
Enrollment target
7
Study locations

Study Summary

The primary objective of this study is to evaluate Ubiquitin C-terminal Hydrolase-L1 (UCH-L1) and Glial Fibrillary Acidic Protein (GFAP) biomarker levels in a population of CT-positive subjects (as determined by an independent Neuroimaging Review Committee) presenting acutely with traumatic brain injury (Glasgow Coma Scale score 9-15).

Conditions Studied

Traumatic Brain Injury

Interventions

  • OTHER Blood draw within 12 hours of head injury

Study Locations (7)

Virginia

  • University of Virginia - Charlottesville
  • Virginia Commonwealth University - Richmond

Other

  • Ludwig-Maximilians-University - Munich
  • Klinikum rechts der Isar of the Technical University of Munich - Munich

California

  • University of California San Diego - San Diego

Michigan

  • Wayne State University - Detroit Receiving Hospital - Detroit

Texas

  • Baylor College of Medicine/Ben Taub General Hospital - Houston

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2015-06
Est. Completion 2016-11

Sponsor

Banyan Biomarkers

8 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02439736

The ClinicalTrials.gov registry entry for NCT02439736 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (57% lower). The listed sponsor is Banyan Biomarkers, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Blood draw within 12 hours of head injury is the first listed.

NCT02439736 reports 7 study locations spanning 5 distinct geographic areas - top geographies include Virginia, Other, California.

Frequently Asked Questions

What is clinical trial NCT02439736 about?

NCT02439736 is a clinical study titled "Evaluation OF Biomarkers OF Traumatic Brain Injury Extension Study". The primary objective of this study is to evaluate Ubiquitin C-terminal Hydrolase-L1 (UCH-L1) and Glial Fibrillary Acidic Protein (GFAP) biomarker levels in a population of CT-positive subjects (as determined by an independent Neuroimaging Review Committee) presenting acutely with traumatic brain in...

What is the current status of trial NCT02439736?

This trial is currently completed. The enrollment target is 119 participants. The study started on 2015-06. Estimated completion is 2016-11.

What conditions does trial NCT02439736 study?

This clinical trial studies the following conditions: Traumatic Brain Injury.

What interventions are being tested in trial NCT02439736?

The interventions under investigation include: Blood draw within 12 hours of head injury (OTHER).

Who is sponsoring clinical trial NCT02439736?

This trial is sponsored by Banyan Biomarkers, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02439736 being conducted?

This trial has 7 study locations across California, Michigan, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Traumatic Brain Injury

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.